Journal
/
Immunology and Infection
/
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
JoVE Journal
Immunology and Infection
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Immunology and Infection
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

English

Automatically Generated

6,371 Views

•

07:25 min

•

September 25, 2019

DOI:

10.3791/60043-v

DOI:
10.3791/60043-v

•

07:25 min
September 25, 2019

•

15 Views
, , ,
1Department of Microbial Pathogenesis and Immunology,Texas A&M University Health Science Center, 2Department of Ophthalmology,Harvard Medical School

Summary

Automatically generated

Presented here is a protocol for the effective suppression of hepatitis B virus (HBV) replication in mice by utilizing adoptive cell transfer (ACT) of stem cell-derived viral antigen (Ag)-specific T lymphocytes. This procedure may be adapted for potential ACT-based immunotherapy of HBV infection.

Explore More Videos

Stem CellViral Antigen-specific T LymphocytesHBV ReplicationIPSC-derived T CellsAdoptive Cell TransferT Cell ReceptorHBV PlasmidHydrodynamic DeliveryCD8-positive T Cells

Read Article

Cite this Article

Xiong, X., Lei, F., Haque, M., Song, J. Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice. J. Vis. Exp. (151), e60043, doi:10.3791/60043 (2019).

Download .ris file

Copy

Share Video

.

Copy